A Diagnostic Biopsy-Adapted Immunoscore Predicts Response to Neoadjuvant Treatment and Selects Patients with Rectal Cancer Eligible for a Watch-and-Wait Strategy

2020104 citationsJournal Articlebronze Open Access

Authors

Carine El Sissy

Amos Kirilovsky

Marc Van den Eynde

Ana-Maria Mușină

Maria-Gabriela Aniței

Abstract

IS<sub>B</sub> predicts response to nT and survival in patients with LARC treated by surgery. Its usefulness in the selection of patients eligible for a Watch-and-Wait strategy is strongly suggested.

Topics & Keywords

Colorectal Cancer Surgical Treatments Colorectal Cancer Treatments and Studies Colorectal and Anal Carcinomas

UN Sustainable Development Goals

Reduced inequalities

Publication Details

Published in: Clinical Cancer Research

Volume 26, Issue 19, pp. 5198-5207

DOI: 10.1158/1078-0432.ccr-20-0337

Field-Weighted Citation Impact: 6.19